Anniina Snellman
Docent
aepakk@utu.fi +358 0 231 3872 Kiinamyllynkatu 4-8 Turku |
- Effects of pre-analytical procedures on blood biomarkers for Alzheimer's pathophysiology, glial activation, and neurodegeneration (2021)
- Alzheimer's & dementia: diagnosis, assessment & disease monitoring
- Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease (2021)
- JAMA Neurology
- Plasma levels of phosphorylated tau 181 are associated with cerebral metabolic dysfunction in cognitively impaired and amyloid-positive individuals (2021)
- Brain Communications
- Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study (2021)
- Theranostics
- P-tau235: a novel biomarker for staging preclinical Alzheimer's disease (2021)
- Embo molecular medicine
- (S)-[18F]THK5117 brain uptake is associated with Aβ plaques and MAO-B enzyme in a mouse model of Alzheimer's disease (2021)
- Neuropharmacology
- Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum (2021)
- Brain
- Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease (2021)
- Journal of Internal Medicine
- Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer's Disease Neuroimaging Initiative (2020)
- Molecular Psychiatry
- Effect of genotype and age on cerebral [F-18]FDG uptake varies between transgenic APP(swe)-PS1(dE9) and Tg2576 mouse models of Alzheimer's disease (2019)
- Scientific Reports



